Polymer Surface Topography for Implantable Sensor Inflammation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Implanted glucose sensors face challenges due to host immune responses, which inhibit glucose diffusion and compromise accuracy over time, as the mammalian host response to foreign materials leads to inflammatory reactions and fibrous capsule formation, hindering the function of medical devices.
Innovation Solution
Development of medical devices with polymer surfaces featuring a carbon-to-oxygen ratio greater than 5, surface hydrophobicity between 75° and 90°, and specific topographies such as grooves, wells, or grids, which influence macrophages to differentiate into anti-inflammatory phenotypes, reducing inflammatory responses and enhancing device functionality.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional polymer surfaces are used for implantable glucose sensors, then device simplicity and ease of manufacture are maintained, but host immune responses occur leading to fibrous capsule formation that isolates the device and inhibits glucose diffusion
Solution Approach 1:
The patent applies parameter changes by modifying the polymer surface to exhibit specific characteristics: a carbon-to-oxygen ratio greater than 5, surface hydrophobicity between 75° and 90°, and controlled topography with grooves, wells, or grids. These parameter modifications cause macrophages to differentiate into anti-inflammatory M2 phenotypes rather than pro-inflammatory M1 phenotypes, thereby reducing fibrous capsule formation and maintaining glucose diffusion while preserving sensor accuracy.
2Reliability
If polymer surfaces with specific topography and composition are engineered to reduce immune response, then inflammatory responses and fibrous capsule formation are reduced, but device complexity and manufacturing difficulty increase
Solution Approach 1:
The patent achieves reduced immune response by controlling specific polymer surface parameters: carbon-to-oxygen ratio >5, surface hydrophobicity of 75°-90°, and topographic features including grooves (0.3-5 μm peak-to-valley height), wells (1-2 μm peak-to-valley height), or grids (2-4 μm peak-to-valley height). These engineered parameters guide macrophage differentiation toward anti-inflammatory M2 phenotypes, reducing fibrous capsule formation while maintaining manufacturability through controlled surface treatment processes.
Data Source
AI summary
Embodiments of the invention provide optimized polymeric surfaces adapted for use with implantable medical devices as well as methods for making and using such polymeric surfaces. These polymer surfaces have a constellation of features that function to inhibit or avoid an inflammatory immune response generated by implantable medical devices. Typical embodiments of the invention include an implantable glucose sensor used in the management of diabetes having a polymer surface with the disclosed constellation of features.